Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
17,640,683
-
Shares change
-
+1,699,128
-
Total reported value, excl. options
-
$228,620,171
-
Value change
-
+$25,329,638
-
Put/Call ratio
-
235%
-
Number of buys
-
37
-
Number of sells
-
-30
-
Price
-
$12.96
Significant Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q2 2016
85 filings reported holding BLCM - BELLICUM PHARMACEUTICALS INC - COM as of Q2 2016.
BELLICUM PHARMACEUTICALS INC - COM (BLCM) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,640,683 shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (4,865,647 shares), FMR LLC (2,393,544 shares), JPMORGAN CHASE & CO (2,355,386 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,126,336 shares), BlackRock Fund Advisors (883,201 shares), First Eagle Investment Management, LLC (854,055 shares), VANGUARD GROUP INC (751,584 shares), FRANKLIN RESOURCES INC (686,500 shares), QVT Financial LP (507,939 shares), and MORGAN STANLEY (412,340 shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.